Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Want to get the latest psychedelics industry news in your inbox every week? Subscribe to our Newsletter to become a Psychedelic...
Numinus Wellness Inc.
Medical Psychedelics have made it into Davos, just in time for the World Economic Forum.
After a period of clinical pilot, Novamind Inc. (OTCQB: NVMDF) will offer Frontline KAP, group-based ketamine-assisted psychoth...
The psychedelics space got a new glimpse at the financials of some of its heavy hitters with the release of earnings reports fo...
June 8, 2022 marks a turning point for both Numinus (OTCQX: NUMIF) and Novamind (OTCQB: NVMDF).
The world’s richest man gave another public nod to psychedelics medicine in favor of traditional mental health solutions.
Novamind (OTCQB: NVMDF), which is to be acquired by Numinus Wellness (OTCMKTS: NUMIF), recently announced a collaboration with ...
In a year where M&A activity is expected to ratchet-up in 2022, Numinus Wellness Inc. (OTC: NUMIF) is among the first to ta...
